{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:14Z","timestamp":1792507514954,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10067-019-04882-x","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T18:03:34Z","timestamp":1576260214000},"page":"957-961","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-7023","authenticated-orcid":false,"given":"George E","family":"Fragoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Chatzidionysiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"4882_CR1","first-page":"62","volume":"29","author":"C Turesson","year":"2002","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29:62\u201367","journal-title":"J Rheumatol"},{"key":"4882_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","volume":"46","author":"Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, Dixey J, Early Rheumatoid Arthritis Study g","year":"2007","unstructured":"Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, Dixey J, Early Rheumatoid Arthritis Study g (2007) Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 46:350\u2013357. https:\/\/doi.org\/10.1093\/rheumatology\/kel253","journal-title":"Rheumatology (Oxford)"},{"key":"4882_CR3","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1186\/ar2404","volume":"10","author":"AL Smitten","year":"2008","unstructured":"Smitten AL, Simon TA, Hochberg MC, Suissa S (2008) A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 10:R45. https:\/\/doi.org\/10.1186\/ar2404","journal-title":"Arthritis Res Ther"},{"key":"4882_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","volume":"17","author":"TA Simon","year":"2015","unstructured":"Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 17:212. https:\/\/doi.org\/10.1186\/s13075-015-0728-9","journal-title":"Arthritis Res Ther"},{"key":"4882_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.semarthrit.2007.08.006","volume":"37","author":"Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L, Group ES","year":"2008","unstructured":"Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L, Group ES (2008) Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum 37:388\u2013397. https:\/\/doi.org\/10.1016\/j.semarthrit.2007.08.006","journal-title":"Semin Arthritis Rheum"},{"key":"4882_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10067-018-4382-x","volume":"38","author":"Q Fu","year":"2019","unstructured":"Fu Q, Wang L, Li L, Li Y, Liu R, Zheng Y (2019) Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population. Clin Rheumatol 38:1109\u20131116. https:\/\/doi.org\/10.1007\/s10067-018-4382-x","journal-title":"Clin Rheumatol"},{"key":"4882_CR7","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.21037\/jtd.2018.06.62","volume":"10","author":"X Liu","year":"2018","unstructured":"Liu X, Xu Y, Zhou Q, Chen M, Liang H, Zhao J, Zhong W, Wang M (2018) Clinicopathological features of lung cancer in patients with rheumatoid arthritis. J Thorac Dis 10:3965\u20133972. https:\/\/doi.org\/10.21037\/jtd.2018.06.62","journal-title":"J Thorac Dis"},{"key":"4882_CR8","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/acr.22882","volume":"68","author":"RM Joseph","year":"2016","unstructured":"Joseph RM, Movahedi M, Dixon WG, Symmons DP (2016) Smoking-related mortality in patients with early rheumatoid arthritis: a retrospective cohort study using the clinical practice research datalink. Arthritis Care Res (Hoboken) 68:1598\u20131606. https:\/\/doi.org\/10.1002\/acr.22882","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4882_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3109\/03009741003604542","volume":"39","author":"A Nakajima","year":"2010","unstructured":"Nakajima A, Inoue E, Tanaka E, Singh G, Sato E, Hoshi D, Shidara K, Hara M, Momohara S, Taniguchi A, Kamatani N, Yamanaka H (2010) Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol 39:360\u2013367. https:\/\/doi.org\/10.3109\/03009741003604542","journal-title":"Scand J Rheumatol"},{"key":"4882_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00296-016-3638-5","volume":"37","author":"J van den Hoek","year":"2017","unstructured":"van den Hoek J, Boshuizen HC, Roorda LD, Tijhuis GJ, Nurmohamed MT, van den Bos GA, Dekker J (2017) Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatol Int 37:487\u2013493. https:\/\/doi.org\/10.1007\/s00296-016-3638-5","journal-title":"Rheumatol Int"},{"key":"4882_CR11","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/acr.23548","volume":"70","author":"J Widdifield","year":"2018","unstructured":"Widdifield J, Paterson JM, Huang A, Bernatsky S (2018) Causes of death in rheumatoid arthritis: how do they compare to the general population? Arthritis Care Res (Hoboken) 70:1748\u20131755. https:\/\/doi.org\/10.1002\/acr.23548","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4882_CR12","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/art.22527","volume":"56","author":"DL Mattey","year":"2007","unstructured":"Mattey DL, Thomson W, Ollier WE, Batley M, Davies PG, Gough AK, Devlin J, Prouse P, James DW, Williams PL, Dixey J, Winfield J, Cox NL, Koduri G, Young A (2007) Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum 56:1408\u20131416. https:\/\/doi.org\/10.1002\/art.22527","journal-title":"Arthritis Rheum"},{"key":"4882_CR13","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/rheumatology\/ker143","volume":"50","author":"J Ji","year":"2011","unstructured":"Ji J, Liu X, Sundquist K, Sundquist J (2011) Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford) 50:1513\u20131518. https:\/\/doi.org\/10.1093\/rheumatology\/ker143","journal-title":"Rheumatology (Oxford)"},{"key":"4882_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/annrheumdis-2014-207155","volume":"75","author":"JF Simard","year":"2016","unstructured":"Simard JF, Ekberg S, Johansson AL, Askling J (2016) What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer? Ann Rheum Dis 75:862\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207155","journal-title":"Ann Rheum Dis"},{"key":"4882_CR15","doi-asserted-by":"publisher","unstructured":"Lim XR, Xiang W, Tan JWL, Koh LW, Lian TY, Leong KP, Koh ET, Group TRAS (2019) Incidence and patterns of malignancies in a multi-ethnic cohort of rheumatoid arthritis patients. Int J Rheum Dis. https:\/\/doi.org\/10.1111\/1756-185X.13655","DOI":"10.1111\/1756-185X.13655"},{"key":"4882_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00296-010-1524-0","volume":"31","author":"T Yamada","year":"2011","unstructured":"Yamada T, Nakajima A, Inoue E, Tanaka E, Taniguchi A, Momohara S, Yamanaka H (2011) Incidence of malignancy in Japanese patients with rheumatoid arthritis. Rheumatol Int 31:1487\u20131492. https:\/\/doi.org\/10.1007\/s00296-010-1524-0","journal-title":"Rheumatol Int"},{"key":"4882_CR17","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1136\/ard.2004.033993","volume":"64","author":"J Askling","year":"2005","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Saxne T, Klareskog L (2005) Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 64:1421\u20131426. https:\/\/doi.org\/10.1136\/ard.2004.033993","journal-title":"Ann Rheum Dis"},{"key":"4882_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/rheumatology\/ken130","volume":"47","author":"K Hemminki","year":"2008","unstructured":"Hemminki K, Li X, Sundquist K, Sundquist J (2008) Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology (Oxford) 47:698\u2013701. https:\/\/doi.org\/10.1093\/rheumatology\/ken130","journal-title":"Rheumatology (Oxford)"},{"key":"4882_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115\u2013132. https:\/\/doi.org\/10.3322\/caac.21338","journal-title":"CA Cancer J Clin"},{"key":"4882_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/art.30134","volume":"63","author":"YJ Chen","year":"2011","unstructured":"Chen YJ, Chang YT, Wang CB, Wu CY (2011) The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan. Arthritis Rheum 63:352\u2013358. https:\/\/doi.org\/10.1002\/art.30134","journal-title":"Arthritis Rheum"},{"key":"4882_CR21","doi-asserted-by":"publisher","unstructured":"Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R (2019) Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment. Front Med 6. https:\/\/doi.org\/10.3389\/fmed.2019.00238","DOI":"10.3389\/fmed.2019.00238"},{"key":"4882_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40744-017-0064-4","volume":"4","author":"KM Wilton","year":"2017","unstructured":"Wilton KM, Matteson EL (2017) Malignancy incidence, management, and prevention in patients with rheumatoid arthritis. Rheumatol Ther 4:333\u2013347. https:\/\/doi.org\/10.1007\/s40744-017-0064-4","journal-title":"Rheumatol Ther"},{"key":"4882_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.lungcan.2007.06.013","volume":"59","author":"S Bernatsky","year":"2008","unstructured":"Bernatsky S, Clarke A, Suissa S (2008) Lung cancer after exposure to disease modifying anti-rheumatic drugs. Lung Cancer 59:266\u2013269. https:\/\/doi.org\/10.1016\/j.lungcan.2007.06.013","journal-title":"Lung Cancer"},{"key":"4882_CR24","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/art.23716","volume":"59","author":"R Buchbinder","year":"2008","unstructured":"Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, Harkness A, Lewis D, Littlejohn G, Miller MH, Ryan PF, Jolley D (2008) Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 59:794\u2013799. https:\/\/doi.org\/10.1002\/art.23716","journal-title":"Arthritis Rheum"},{"key":"4882_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","volume":"52","author":"Mercer LK, Davies R, Galloway JB, Low A, Lunt M, Dixon WG, Watson KD, Symmons DP, Hyrich KL, British Society for Rheumatology Biologics Register Control Centre C","year":"2013","unstructured":"Mercer LK, Davies R, Galloway JB, Low A, Lunt M, Dixon WG, Watson KD, Symmons DP, Hyrich KL, British Society for Rheumatology Biologics Register Control Centre C (2013) Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology (Oxford) 52:91\u201398. https:\/\/doi.org\/10.1093\/rheumatology\/kes350","journal-title":"Rheumatology (Oxford)"},{"key":"4882_CR26","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10067-015-3026-7","volume":"34","author":"N Berghen","year":"2015","unstructured":"Berghen N, Teuwen LA, Westhovens R, Verschueren P (2015) Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study. Clin Rheumatol 34:1687\u20131695. https:\/\/doi.org\/10.1007\/s10067-015-3026-7","journal-title":"Clin Rheumatol"},{"key":"4882_CR27","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275\u20132285. https:\/\/doi.org\/10.1001\/jama.295.19.2275","journal-title":"JAMA"},{"key":"4882_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/annrheumdis-2013-204851","volume":"74","author":"Mercer LK, Lunt M, Low AL, Dixon WG, Watson KD, Symmons DP, Hyrich KL, Consortium BCC","year":"2015","unstructured":"Mercer LK, Lunt M, Low AL, Dixon WG, Watson KD, Symmons DP, Hyrich KL, Consortium BCC (2015) Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 74:1087\u20131093. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204851","journal-title":"Ann Rheum Dis"},{"key":"4882_CR29","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/ar2904","volume":"12","author":"A Strangfeld","year":"2010","unstructured":"Strangfeld A, Hierse F, Rau R, Burmester GR, Krummel-Lorenz B, Demary W, Listing J, Zink A (2010) Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT. Arthritis Res Ther 12:R5. https:\/\/doi.org\/10.1186\/ar2904","journal-title":"Arthritis Res Ther"},{"key":"4882_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4143\/crt.2017.119","volume":"50","author":"WI Choi","year":"2018","unstructured":"Choi WI, Park SH, Park BJ, Lee CW (2018) Interstitial lung disease and lung cancer development: a 5-year nationwide population-based study. Cancer Res Treat 50:374\u2013381. https:\/\/doi.org\/10.4143\/crt.2017.119","journal-title":"Cancer Res Treat"},{"key":"4882_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010071","volume":"97","author":"HI Jung","year":"2018","unstructured":"Jung HI, Park JS, Lee MY, Park B, Kim HJ, Park SH, Choi WI, Lee CW (2018) Prevalence of lung cancer in patients with interstitial lung disease is higher than in those with chronic obstructive pulmonary disease. Medicine (Baltimore) 97:e0071. https:\/\/doi.org\/10.1097\/MD.0000000000010071","journal-title":"Medicine (Baltimore)"},{"key":"4882_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12931-019-1094-y","volume":"20","author":"WI Choi","year":"2019","unstructured":"Choi WI, Lee DY, Choi HG, Lee CW (2019) Lung cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year nationwide population-based study. Respir Res 20:117. https:\/\/doi.org\/10.1186\/s12931-019-1094-y","journal-title":"Respir Res"},{"key":"4882_CR33","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1200\/JCO.2006.07.1381","volume":"24","author":"C Siemes","year":"2006","unstructured":"Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam study. J Clin Oncol 24:5216\u20135222. https:\/\/doi.org\/10.1200\/JCO.2006.07.1381","journal-title":"J Clin Oncol"},{"key":"4882_CR34","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/art.27402","volume":"62","author":"K Hellgren","year":"2010","unstructured":"Hellgren K, Smedby KE, Feltelius N, Baecklund E, Askling J (2010) Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis. Arthritis Rheum 62:1252\u20131258. https:\/\/doi.org\/10.1002\/art.27402","journal-title":"Arthritis Rheum"},{"key":"4882_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/bmj.317.7152.180","volume":"317","author":"E Baecklund","year":"1998","unstructured":"Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L (1998) Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 317:180\u2013181. https:\/\/doi.org\/10.1136\/bmj.317.7152.180","journal-title":"BMJ"},{"key":"4882_CR36","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, Klareskog L (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54:692\u2013701. https:\/\/doi.org\/10.1002\/art.21675","journal-title":"Arthritis Rheum"},{"key":"4882_CR37","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s10552-009-9298-y","volume":"20","author":"A Parikh-Patel","year":"2009","unstructured":"Parikh-Patel A, White RH, Allen M, Cress R (2009) Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control 20:1001\u20131010. https:\/\/doi.org\/10.1007\/s10552-009-9298-y","journal-title":"Cancer Causes Control"},{"key":"4882_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/BOR.0000000000000238","volume":"28","author":"A Chatzidionisyou","year":"2016","unstructured":"Chatzidionisyou A, Catrina AI (2016) The lung in rheumatoid arthritis, cause or consequence? Curr Opin Rheumatol 28:76\u201382. https:\/\/doi.org\/10.1097\/BOR.0000000000000238","journal-title":"Curr Opin Rheumatol"},{"key":"4882_CR39","doi-asserted-by":"publisher","first-page":"A79","DOI":"10.1136\/annrheumdis-2016-209124.188","volume":"75","author":"K Chatzidionysiou","year":"2016","unstructured":"Chatzidionysiou K, Reynisdottir G, Joshua V, Frisell T, Askling J, Catrina A (2016) A10.16 risk for lung cancer in ra and different ra phenotypes: results from a population-based case-control study. Ann Rheum Dis 75:A79\u2013A79. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209124.188","journal-title":"Ann Rheum Dis"},{"key":"4882_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3322\/caac.21392","volume":"67","author":"RA Smith","year":"2017","unstructured":"Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC (2017) Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 67:100\u2013121. https:\/\/doi.org\/10.3322\/caac.21392","journal-title":"CA Cancer J Clin"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04882-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04882-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04882-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T01:05:14Z","timestamp":1607735114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04882-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4882"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04882-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"23 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}